Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Method Development and Validation of Aliskiren Hemifumarate and Valsartan in bulk drug by RP-HPLC method


Affiliations
1 Nalanda College of Pharmacy, Nalgonda, Andhra Pradesh, 508001, India
2 Mylan Laboratories Ltd, Hyderabad, Andhra Pradesh, India
     

   Subscribe/Renew Journal


A new simple, accurate, rapid and precise isocratic High Performance Liquid Chromatographic (HPLC) method was developed and validated for the determination of Aliskiren Hemifumarate (ALSK) and Valsartan (VAL) in bulk drug. The Method employs Waters HPLC system on C8 Column (4.6 x 250 mm, 5 μm) and flow rate of 1 ml/min with a load of 10μl. The Detection was carried out at 220 nm. mobile phase used as Acetonitrile and Phosphate buffer and Methanol was used as mobile phase in the composition of 45:40:15 , phosphate buffer (0.02Mm) adjusted the pH to 4 with Orthophosphoric acid within a short runtime of 8 min. The retention times of Aliskiren (ALSK) was 3.407 min, Valsartan (VAL) was 4.268 min. The method was validated according to the regulatory guidelines with respect to specificity, precision, accuracy, linearity and robustness etc.

Keywords

Aliskiren Hemifumarate, Valsartan, HPLC, Validation
Subscription Login to verify subscription
User
Notifications
Font Size


  • http://www.drugbank.ca/drugs/DB00177
  • Willard HH, Merritt LL, Dean JJA, Frank AS. Instrumental Method of Analysis. CBS Publishers and Distributors, New Delhi. 1986; 9th ed: pp. 580, 626.
  • Sethi PD. High-performance liquid chromatography. CBS Publishers and Distributors, New Delhi. 2001 1,1-103,.
  • Kemp WL. Organic Spectroscopy. Macmillan. 1991; 3rd ed: pp. 234-267. 5. http://www.drugbank.ca/drugs/DB01258
  • Tatar S, Saglik S, Comparison of UV- and Second derivative- Spectrophotometric and LC methods for the determination of Valsartan in pharmaceutical formulation, Journal of Pharmaceutical and Biomedical Analysis, 30(2); 2002: 371-375.
  • Macek J., Klima J. and Ptacek P.,“Rapid determination of Valsartan in human plasma by protein precipitation and high-performance liquid chromatography”, Journal of Chromatography, 832(1); 2007: 169-172.
  • Pachauri SL, Paliwal SV, Srinivas KS, Singh YG, Jain VR. Development and validation of HPLC method for analysis of some antihypertensive agents in their pharmaceutical dosage forms. Journal of Pharmaceutical sciences and Research. 2 (8); 2010: 459-464.
  • Sangoi MW, Sangoi MS, Oliveira PR, Secretti LT, and Rolim CB. Determination of aliskiren in tablet dosage forms by a validated stability indicating RP-LC method. Journal of Chromatographic Science, 49(2); 2011: 170-175.
  • Swamy GK , Rao JS, Kumar JR, Kumar UA, Bikshapathi DR, Kumar DV. Analytical method development and validation of aliskiren in bulk and tablet dosage form by RP-HPLC method. Journal of Pharmacy Research, 4(3); 2011: 865-867.
  • Satish KB, Rao JS, and Bhargava KV. A simple and sensitive method for the determination of aliskiren hemifumarate using HPLC-UV detection. Rasayan Journal Chemistry, 4(2); 2011: 285-288.
  • Satana E, Altinay S, Göger N., Özkanb S. A., Sentürk Z.,Simultaneous determination of valsartan and hydrochlorothiazide in tablets by firstderivative ultraviolet spectrophotometry and LC, J. Pharm. Biomed. Anal, 25(5-6): 1009-1013.
  • Shaboury SE, Hussein SA, Mohamed NA, Mohamed MS, Spectrofluorimetric method for determination of some angiotensin II receptor antagonists, Journal of Pharmaceutical Analysis, 2(1); 2012: 12-18.
  • Yadav BR, Moinuddin MD, Battu RK, Samanthula GD, Development and Validation of a New RP-HPLC Method for the Estimation of Valsartan and Hydrochlorothiazide in Tablets, Journal of Analytical Chemistry, 2(8); 2012: 13-19.
  • Patnaik A, Shetty M, Sahoo S, Nayak DK, Veliyath SK, A new rp-hplc method for the determination of valsartan in bulk and its pharmaceutical formulations with it’s stability indicative studies. International Journal of Pharmaceutical Sciences, 2(3); 2011: 43-53.

Abstract Views: 534

PDF Views: 2




  • Method Development and Validation of Aliskiren Hemifumarate and Valsartan in bulk drug by RP-HPLC method

Abstract Views: 534  |  PDF Views: 2

Authors

Somsubhra Ghosh
Nalanda College of Pharmacy, Nalgonda, Andhra Pradesh, 508001, India
B. Anusha
Nalanda College of Pharmacy, Nalgonda, Andhra Pradesh, 508001, India
Santhoshi
Nalanda College of Pharmacy, Nalgonda, Andhra Pradesh, 508001, India
David Banji
Nalanda College of Pharmacy, Nalgonda, Andhra Pradesh, 508001, India
Y. Chaithanya Kumar
Nalanda College of Pharmacy, Nalgonda, Andhra Pradesh, 508001, India
P. Raghavendra
Nalanda College of Pharmacy, Nalgonda, Andhra Pradesh, 508001, India
Subhadip Roy
Mylan Laboratories Ltd, Hyderabad, Andhra Pradesh, India

Abstract


A new simple, accurate, rapid and precise isocratic High Performance Liquid Chromatographic (HPLC) method was developed and validated for the determination of Aliskiren Hemifumarate (ALSK) and Valsartan (VAL) in bulk drug. The Method employs Waters HPLC system on C8 Column (4.6 x 250 mm, 5 μm) and flow rate of 1 ml/min with a load of 10μl. The Detection was carried out at 220 nm. mobile phase used as Acetonitrile and Phosphate buffer and Methanol was used as mobile phase in the composition of 45:40:15 , phosphate buffer (0.02Mm) adjusted the pH to 4 with Orthophosphoric acid within a short runtime of 8 min. The retention times of Aliskiren (ALSK) was 3.407 min, Valsartan (VAL) was 4.268 min. The method was validated according to the regulatory guidelines with respect to specificity, precision, accuracy, linearity and robustness etc.

Keywords


Aliskiren Hemifumarate, Valsartan, HPLC, Validation

References